The news from Pfizer and Arcturus over these last few days gives one reason to believe that a viable vaccine will be available to many across the globe in the next few months.
When approved, the next challenge will be to safely and securely ship these vaccines to where they will be available to citizens in every part of a country. The likely possibility that these vaccines will require shipment at temperatures below zero degrees Celsius will further compound accessibility.
